NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma
Glioma is one of the most deadly types of brain cancer. As it is highly invasive, the prognosis for glioma patients remains dismal, with median survival rarely exceeding 16 months. Thus, developing a new prognostic biomarker for glioma and investigating its molecular mechanisms is necessary for the...
Main Authors: | Guangrong Zheng, Tao Han, Xiaomu Hu, Zhou Yang, Jin Wang, Zhenyi Wen, Hengyu Li, Hongjin Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.770628/full |
Similar Items
-
NCAPG2 Is a Novel Prognostic Biomarker and Promotes Cancer Stem Cell Maintenance in Low-Grade Glioma
by: Wenjun Ren, et al.
Published: (2022-07-01) -
Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer
by: Sun DP, et al.
Published: (2020-08-01) -
NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway
by: Yun Wu, et al.
Published: (2021-08-01) -
NCAPG2 could be an immunological and prognostic biomarker: From pan-cancer analysis to pancreatic cancer validation
by: Qi Wang, et al.
Published: (2023-01-01) -
NCAPG stimulates lung adenocarcinoma cell stemness through aerobic glycolysis
by: Zuwang Zhang, et al.
Published: (2023-09-01)